Nabsys raises $21M for sequencing tech; Supreme Court to hear 'pay for delay' arguments;

 @FierceBiotech: Editor's corner: Will biotech grow in China and India without much VC help? More | Follow @FierceBiotech

@JohnCFierce: Weird deal. Receptos gets a PhII-ready AbbVie antibody. AbbVie has option to co-dev, co-promote. If it's worth anything, why farm it out? | Follow @JohnCFierce

@RyanMFierce: Takeda expanded a discovery alliance with Sripps Florida (pharma outsourcing more discovery work to academics.) Release | Follow @RyanMFierce

> Sequencing tech startup Nabsys has raised $21 million, with Bay City Capital leading the Series D. Story

> The big showdown between pharma companies and the FTC over "pay for delay" deals will soon be in the hands of the Supreme Court. Story

Pharma News

@FiercePharma: India's Lupin joins hunt for branded products to beef up a generics portfolio. Has $1B to spend. Report | Follow @FiercePharma

@EricPFierce: Bayer & Merck have weighed in on the big pay-for-delay case that the Supreme Court takes up this month. More | Follow @EricPFierce

> Bayer, Merck join fight against FTC in pay-for-delay case. More

> Merck hid Fosamax's links to femur fractures, lawyer says. More

Medical Device News

 @FierceMedDev: For GenMark, more flu was good news in 2012. More | Follow @FierceMedDev

 @MarkHFierce: France's EyeTechCare, with $13M in new funding, will pursue U.S. approval of its glaucoma ultrasound medical device. More | Follow @MarkHFierce

 @DamianFierce: Luminex is on board to handle companion diagnostics for Merck's blockbuster hopeful Alzheimer's drug. More | Follow @DamianFierce

> Analysts: Life Tech's suitors may balk at $15B price tag. More

> Zoll wins German patent battle over intravascular temperature management tech. More

Drug Delivery News

@MichaelGFierce: Vaginal nanogel with bee venom could prevent HIV infection. Story | Follow @MichaelGFierce

> Terumo evens with Abbott's Xience in drug-eluting stent study. News

> Study: Artificial pancreas improves overnight care in diabetic children. Article

> Shape-shifting proteins could aid drug delivery for cancer, infections. More

> Celgene drops $13M on Presage's 3-D drug delivery platform. Report

> PolyPid, MIS Implants partner for drug delivering dental bone-filler. Item

And Finally… A new survey finds that doctors often prescribe cholesterol-lowering drugs to patients who are unlikely to benefit from them. Story

Suggested Articles

All 12 members of an FDA advisory committee voted to recommend the approval of teprotumumab for a rare, autoimmune eye disease.

Early data out of former Fierce 15 winner Gritstone Oncology have been heralded as a big win for the early-stage biotech by analysts.

Biogen will drop work on gosuranemab in progressive supranuclear palsy but continue on in Alzheimer's.